dm+d

13868111000001109

Articles

What injections can be given orally or via enteral feeding tubes?

6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…

Safety in Lactation: Antimuscarinic drugs

5 November 2020These antimuscarinics are used as premedication, to dry secretions, and for intraoperative bradycardia. They are given as a single dose by injection, repeated if necessary…

Safety in Lactation: Drugs used in nausea and vertigo

21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. The choice of anti-emetic will depend…

Hypersalivation – can hyoscine hydrobromide be used to treat it?

1 August 2018This Medicines Q&A evaluates the available evidence for the use of hyoscine hydrobromide for the management of non drug-induced hypersalivation. Update November 2020: this Q&A…

Hypersalivation – what drug treatment options are available?

1 August 2018This Medicines Q&A is one of a series of five Q&A documents to address the drug treatment of hypersalivation (drooling or sialorrhoea). It gives a…
Search Articles

Medicine Compliance Aid Stability

Joy RidesGlaxoSmithKline UK

GlaxoSmithKline UK
Joy Rides
Tablets chewable 150 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers and protect from light.
21 January 2015

Kwells KidsBayer plc

Bayer plc
Kwells Kids
Tablets chewable 150 micrograms
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light.
21 January 2015

Lactation Safety Information

As anti-emetic

As anti-emetic
-
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Occasional, short-term use considered compatible with breastfeeding. Repeated use may interfere with lactation
Used in infants >1 month
Preferred drug for motion sickness
23 September 2020

For premedication and bradycardia

For premedication and bradycardia
Yes
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
23 September 2020